Vaccines and routine immunization strategies during the COVID-19 pandemic
Severe acute respiratory syndrome coronavirus 2 related disease (COVID-19) is now responsible for one of the most challenging and concerning pandemics. By August 2020, there were almost 20 million confirmed cases worldwide and well over half-million deaths. Since there is still no effective treatmen...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-02-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2020.1804776 |
_version_ | 1797677294918041600 |
---|---|
author | Ener Cagri Dinleyici Ray Borrow Marco Aurélio Palazzi Safadi Pierre van Damme Flor M. Munoz |
author_facet | Ener Cagri Dinleyici Ray Borrow Marco Aurélio Palazzi Safadi Pierre van Damme Flor M. Munoz |
author_sort | Ener Cagri Dinleyici |
collection | DOAJ |
description | Severe acute respiratory syndrome coronavirus 2 related disease (COVID-19) is now responsible for one of the most challenging and concerning pandemics. By August 2020, there were almost 20 million confirmed cases worldwide and well over half-million deaths. Since there is still no effective treatment or vaccine, non-pharmaceutical interventions have been implemented in an attempt to contain the spread of the virus. During times of quarantine, immunization practices in all age groups, especially routine childhood vaccines, have also been interrupted, delayed, re-organized, or completely suspended. Numerous high-income as well as low- and middle-income countries are now experiencing a rapid decline in childhood immunization coverage rates. We will, inevitably, see serious consequences related to suboptimal control of vaccine-preventable diseases (VPDs) in children concurrent with or following the pandemic. Routine pediatric immunizations of individual children at clinics, mass vaccination campaigns, and surveillance for VPDs must continue as much as possible during pandemic. |
first_indexed | 2024-03-11T22:42:41Z |
format | Article |
id | doaj.art-a647fff1d087420ca80ce8350c5d85fa |
institution | Directory Open Access Journal |
issn | 2164-5515 2164-554X |
language | English |
last_indexed | 2024-03-11T22:42:41Z |
publishDate | 2021-02-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Human Vaccines & Immunotherapeutics |
spelling | doaj.art-a647fff1d087420ca80ce8350c5d85fa2023-09-22T08:51:50ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2021-02-0117240040710.1080/21645515.2020.18047761804776Vaccines and routine immunization strategies during the COVID-19 pandemicEner Cagri Dinleyici0Ray Borrow1Marco Aurélio Palazzi Safadi2Pierre van Damme3Flor M. Munoz4Eskisehir Osmangazi University Faculty of MedicinePublic Health EnglandSanta Casa De São Paulo, School of PediatricsUniversity of AntwerpBaylor College of MedicineSevere acute respiratory syndrome coronavirus 2 related disease (COVID-19) is now responsible for one of the most challenging and concerning pandemics. By August 2020, there were almost 20 million confirmed cases worldwide and well over half-million deaths. Since there is still no effective treatment or vaccine, non-pharmaceutical interventions have been implemented in an attempt to contain the spread of the virus. During times of quarantine, immunization practices in all age groups, especially routine childhood vaccines, have also been interrupted, delayed, re-organized, or completely suspended. Numerous high-income as well as low- and middle-income countries are now experiencing a rapid decline in childhood immunization coverage rates. We will, inevitably, see serious consequences related to suboptimal control of vaccine-preventable diseases (VPDs) in children concurrent with or following the pandemic. Routine pediatric immunizations of individual children at clinics, mass vaccination campaigns, and surveillance for VPDs must continue as much as possible during pandemic.http://dx.doi.org/10.1080/21645515.2020.1804776coronaviruscovid-19immunizationpandemicvaccine |
spellingShingle | Ener Cagri Dinleyici Ray Borrow Marco Aurélio Palazzi Safadi Pierre van Damme Flor M. Munoz Vaccines and routine immunization strategies during the COVID-19 pandemic Human Vaccines & Immunotherapeutics coronavirus covid-19 immunization pandemic vaccine |
title | Vaccines and routine immunization strategies during the COVID-19 pandemic |
title_full | Vaccines and routine immunization strategies during the COVID-19 pandemic |
title_fullStr | Vaccines and routine immunization strategies during the COVID-19 pandemic |
title_full_unstemmed | Vaccines and routine immunization strategies during the COVID-19 pandemic |
title_short | Vaccines and routine immunization strategies during the COVID-19 pandemic |
title_sort | vaccines and routine immunization strategies during the covid 19 pandemic |
topic | coronavirus covid-19 immunization pandemic vaccine |
url | http://dx.doi.org/10.1080/21645515.2020.1804776 |
work_keys_str_mv | AT enercagridinleyici vaccinesandroutineimmunizationstrategiesduringthecovid19pandemic AT rayborrow vaccinesandroutineimmunizationstrategiesduringthecovid19pandemic AT marcoaureliopalazzisafadi vaccinesandroutineimmunizationstrategiesduringthecovid19pandemic AT pierrevandamme vaccinesandroutineimmunizationstrategiesduringthecovid19pandemic AT flormmunoz vaccinesandroutineimmunizationstrategiesduringthecovid19pandemic |